Comparing two different modalities i.e triamcinolone injection inside lesion versus combination of triamcinolone injection with radiofrequency ablation inside lesion in treatment of keloids

Comparative study of combination of Intralesional Triamcinolone and radiofrequency ablation versus Intralesional Triamcinolone in the treatment of keloids - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065942

Enrollment

176

Registered

2024-04-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: intralesional triamcinolone injection and radiofrequency ablation: local anesthesia has to be given and then radiofrequency ablation will be done interlesionally at 3 weeks interval for

Eligibility

Inclusion criteria

Inclusion criteria: Patient in the age group 18 to 60 years and Patient giving consent for therapy are included in study

Exclusion criteria

Exclusion criteria: Patients of age less than 18 years or more than 60 years, pregnant and lactating women, Patient with local/systemic infection, any serious illness, extensive keloids, artificial pacemakers, metals implants and Patients who are previously treated and not giving consent are not included in study

Design outcomes

Primary

Measure	Time frame
Decrease in mean POSAS scoreTimepoint: 15 weeks	—

Secondary

Measure	Time frame
to compare side effectsTimepoint: 15 weeks	—

Countries

India

Contacts

Public ContactBhavana Chaudhary

JNMCH, AMU

madil4@myamu.ac.in8171169131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026